These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33822012)

  • 1. Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry.
    Lucchese G; Flöel A
    Brain; 2021 Jun; 144(5):e43. PubMed ID: 33822012
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome.
    Lunn MP; Carr AC; Keddie S; Pakpoor J; Pipis M; Willison HJ
    Brain; 2021 Jun; 144(5):e47. PubMed ID: 33822006
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism.
    Lucchese G; Flöel A
    Cell Stress Chaperones; 2020 Sep; 25(5):731-735. PubMed ID: 32729001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain Barre Syndrome following delivery in a pregnant woman infected with SARS-CoV-2.
    Tekin AB; Zanapalioglu U; Gulmez S; Akarsu I; Yassa M; Tug N
    J Clin Neurosci; 2021 Apr; 86():190-192. PubMed ID: 33775326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
    Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
    Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
    Gaál T; Szeszák G; Torák G; Salacz P
    Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2-associated Guillain-Barré syndrome: a descriptive and comparative analysis.
    Cárdenas-Rodríguez MA; Meléndez-Flores JD; Villarreal-Garza E; Flores-Alfaro F; Pérez-Arzola AA; De la Fuente-Martínez JA; González-Dávila SE; Chávez-Luévanos B; Estrada-Bellmann I
    Can J Neurol Sci; 2023 Jan; 50(1):135-137. PubMed ID: 35067240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
    Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
    Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent onset of COVID-19 after onset of SARS-CoV-2 associated Guillain-Barre syndrome.
    Scorza FA; Finsterer J
    Travel Med Infect Dis; 2021; 44():102201. PubMed ID: 34774758
    [No Abstract]   [Full Text] [Related]  

  • 11. Post SARS-CoV-2 Guillain-Barré syndrome in a child: case report and review of the literature.
    Al Jaberi M; Shihadat R; Masri A
    Childs Nerv Syst; 2022 Oct; 38(10):2011-2016. PubMed ID: 35461356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome after SARS-CoV-2 infection.
    Kilinc D; van de Pasch S; Doets AY; Jacobs BC; van Vliet J; Garssen MPJ
    Eur J Neurol; 2020 Sep; 27(9):1757-1758. PubMed ID: 32533876
    [No Abstract]   [Full Text] [Related]  

  • 14. Dimensions of SARS-CoV-2 associated Guillain-Barré syndrome.
    Finsterer J; Ghosh R
    J Neuroimmunol; 2021 Aug; 357():577626. PubMed ID: 34116278
    [No Abstract]   [Full Text] [Related]  

  • 15. Variant Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: Case Report and Review of the Literature.
    Donaldson L; Margolin E
    Can J Neurol Sci; 2023 Jan; 50(1):138-140. PubMed ID: 35532270
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
    Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
    Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical cases of Guillain-Barré and Miller-Fisher syndromes linked to COVID-19].
    Jasso-Rangel M; Vargas-Martínez KO; Camacho-Frausto LY; Galindo-Félix A; Román-Esquivel JV; Lara-Ramírez EE
    Rev Med Inst Mex Seguro Soc; 2022 Feb; 60(1):91-95. PubMed ID: 35274917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome.
    Ling L; Bagshaw SM; Villeneuve PM
    CMAJ; 2021 Nov; 193(46):E1766-E1769. PubMed ID: 34810163
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies.
    Finsterer J; Scorza FA; Scorza CA; Fiorini AC
    J Neuroimmunol; 2021 Aug; 357():577609. PubMed ID: 34023795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.